BOSTON (AP) — The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children.
The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function.
The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD.
It’s the first time the FDA has cleared a digital therapy for improving ADHD symptoms, and the first time the agency has ever authorized marketing of a game-based therapy for any condition.
The FDA says it looked at data from multiple studies in more than 600 children. A video of the game shows a character traveling a racecourse-like path in a hover board. Sensory and motor tasks are designed to help the player improve cognitive functioning.
“We’re proud to make history today with FDA’s decision,” Akili CEO Eddie Martucci said in a statement. “We’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.”
LATEST NEWS STORIES:
- Massive aid package stuck in the U.S. Senate
- How scammers are rolling back mileage on digital odometers in 2023
- Denny Laine of The Moody Blues, Wings dies at 79
- Christie faces growing GOP pressure to drop out: ‘He’s dividing the vote’
- Jamie Foxx speaks about health scare in emotional speech: ‘I couldn’t actually walk’